About Fluicell
Fluicell is a publicly listed company based in Goteborg (Sweden) founded in 2012. Microfluidic devices for single-cell experiments in life sciences are developed. Its chief executive, as recorded, is Victoire Viannay. Fluicell offers products and services including Nexocyte Platform, Biopixlar, and BioPen. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Microfluidics. Its legal entity is Fluicell AB.
Company details
Fluicell was founded in 2012 in Gothenburg, Sweden, and operates in the life sciences sector. Microfluidics devices are provided to support single-cell experiments. The portfolio includes Biopen systems as superfusion devices for advanced applications and the Dynaflow Resolve system as a perfusion device for patch clamp experiments, functioning as a secondary ion channel screening platform.
- Headquarters Goteborg, Sweden
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fluicell.com
- Social LinkedIn X Instagram YouTube
- Legal Name Fluicell Ab
- Annual Revenue$651.48 K (USD)222.86as on Dec 31, 2025
- Net Profit-$904.47 K (USD)46.28as on Dec 31, 2025
- EBITDA-$902.3 K (USD)59.67as on Dec 31, 2025
- Latest Funding Round$600.49K (USD), Grant
Mar 2021
- Investors
Products & Services of Fluicell
Fluicell offers a comprehensive portfolio of products and services, including Nexocyte Platform, Biopixlar, and BioPen.
Platform for producing transplantable tissues via bioprinting technology
System for high-resolution bioprinting in tissue engineering
Tool for precise single-cell treatment and applications
Apps and channels of Fluicell
its YouTube channel Fluicell AB has 112 subscribers and 26 videos.
Videos from Fluicell
The most watched videos on Fluicell's YouTube channel, Fluicell AB (112 subscribers). Click a video to play it here.
More on Fluicell AB.
Funding Insights of Fluicell
- Total Rounds 1
- Last Round Grant — $600,492
- First Round $600,492
(Mar 2021)
- Investors Count 1
All 1 funding rounds of Fluicell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $600,492 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Fluicell
Fluicell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Fluicell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fluicell
13 people are tracked at Fluicell (6 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Victoire Viannay | CEO | Leadership |
Jonas Hannestad | Chief Marketing and Communications Officer | Leadership |
Joakim Wahlberg | Chief Financial Officer | Leadership |
Carolina Trkulja | CEO | Leadership |
Gavin D. M. Jeffries | Chief Technology Officer | Leadership |
Alar Ainla | Founder | Leadership |
Niek Welkenhuysen | Technical Product Development Lead | Team |
Vladimir Kirejev | Senior R&D scientist and laboratory manager | Team |
Shijun Xu | Senior Scientist & Project Manager | Team |
Samareh Gharaei | Senior Sales Manager | Team |
Andreas Svanström | Lead Application Scientist | Team |
Avadhesh Kumar Singh | Lead Scientist | Team |
Sanna Sämfors | Application Scientist | Team |
Complete people profiles for Fluicell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Fluicell
Fluicell is a publicly listed company on the OMXSTO with ticker symbol FLUI in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onOMXSTO: FLUI
- Listed entityFluicell AB
- Exchange sectorHealth technology
- ISINSE0023595459
- Share price27.50 SEK (-2.14% on the day) · 2026-10-14
- Market capitalisation38,601,055.00 SEK
- Price to earnings13.5
- EPS (diluted, trailing year)2.04 SEK
- Volume (last session)312
Financials of Fluicell
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 6.0M SEK | -8.3M SEK | -8.3M SEK |
| 2024 | 1.9M SEK | -15.5M SEK | -20.6M SEK |
| 2023 | 3.3M SEK | -26.6M SEK | -27.6M SEK |
| 2022 | 3.2M SEK | -21.6M SEK | -24.8M SEK |
| 2021 | 2.6M SEK | -21.7M SEK | -22.5M SEK |
Detailed financial statements for Fluicell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Fluicell
2 dated milestones of Fluicell across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Fluicell is founded.
- Funding First funding round of $600K.
Web traffic of Fluicell
The website of Fluicell (fluicell.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▲ 8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fluicell
Complete news archive for Fluicell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fluicell
Fluicell was founded in 2012 and raised its 1st funding round 9 years after it was founded.
Fluicell is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Victoire Viannay is the CEO of Fluicell, as recorded in our data.
Annual revenue of Fluicell is $651.48K as on Dec 31, 2025.
Fluicell was founded in 2012 in Gothenburg, Sweden, and operates in the life sciences sector. Microfluidics devices are provided to support single-cell experiments. The portfolio includes Biopen systems as superfusion devices for advanced applications and the Dynaflow Resolve system as a perfusion device for patch clamp experiments, functioning as a secondary ion channel screening platform.
Fluicell offers Nexocyte Platform, Biopixlar, and BioPen.
Yes, Fluicell is publicly traded on OMXSTO under the ticker symbol FLUI.
Fluicell has 1 investor. Key investors include European Union.
Fluicell operates through Fluicell Ab.